Abstract:Background Osteoporosis is a degenerative disease characterized by reduced bone mass, with low peak bone mass being the predominant manifestation during development and having an intrauterine origin. Pregnant women at risk of preterm delivery are commonly treated with dexamethasone to promote fetal lung development. However, pregnant dexamethasone exposure (PDE) can lead to reduced peak bone mass and susceptibility to osteoporosis in offspring. In this study, we aimed to investigate the mechanism of PDE-induced low peak bone mass in female offspring from the perspective of altered osteoclast developmental programming. Methods 0.2 mg/kg.d dexamethasone was injected subcutaneously into rats on gestation days (GDs) 9-20. Some pregnant rats were killed at GD20 to remove fetal rat long bones, the rest were delivered naturally, and some adult offspring rats were given ice water swimming stimulation for two weeks. Results The results showed that the fetal rat osteoclast development was inhibited in the PDE group compared with the control group. In contrast, the adult rat osteoclast function was hyperactivation with reduced peak bone mass. We further found that the promoter region methylation levels of lysyl oxidase (LOX) were decreased, the expression was increased, and the production of reactive oxygen species (ROS) was raised in PDE offspring rat long bone before and after birth. Combined in vivo and in vitro experiments, we confirmed that intrauterine dexamethasone promoted the expression and binding of the glucocorticoid receptor (GR) and estrogen receptor beta(ER beta) in osteoclasts and mediated the decrease of LOX methylation level and increase of expression through upregulation of 10-11 translocator protein 3 ( Tet3). Conclusions Taken together, we confirm that dexamethasone causes osteoclast LOX hypomethylation and high expression through the GR/ER beta/Tet3 pathway, leading to elevated ROS production and that this intrauterine epigenetic programming effect can be carried over to postnatal mediating hyperactivation in osteoclast and reduced peak bone mass in adult offspring. This study provides an experimental basis for elucidating the mechanism of osteoclastmediated intrauterine programming of low peak bone mass in female offspring of PDE and for exploring its early targets for prevention and treatment.

LOX Overexpression Programming Mediates the Osteoclast Mechanism of Low Peak Bone Mass in Female Offspring Rats Caused by Pregnant Dexamethasone Exposure

The Mir-98-3p/jag1/notch1 Axis Mediates the Multigenerational Inheritance of Osteopenia Caused by Maternal Dexamethasone Exposure in Female Rat Offspring

Low-activity programming of the PDGFRβ/FAK pathway mediates H-type vessel dysplasia and high susceptibility to osteoporosis in female offspring rats after prenatal dexamethasone exposure

Increased H3K27ac level of ACE mediates the intergenerational effect of low peak bone mass induced by prenatal dexamethasone exposure in male offspring rats

Positive Programming of the GC-IGF1 Axis Mediates Adult Osteoporosis Susceptibility in Male Offspring Rats Induced by Prenatal Dexamethasone Exposure.

Inhibition of Mir-6215 Rescued Low Subchondral Bone Mass Caused by Maternal Exposure to Dexamethasone in Female Offspring Rats.

Prenatal dexamethasone exposure reduces osteoprogenitor proliferation in mice via histone modifications at the Mkp-1 gene locus

11Β-Hydroxysteroid Dehydrogenase 2: A Key Mediator of High Susceptibility to Osteoporosis in Offspring after Prenatal Dexamethasone Exposure.

MiR-17-5p/FOXL2/CDKN1B Signal Programming in Oocytes Mediates Transgenerational Inheritance of Diminished Ovarian Reserve in Female Offspring Rats Induced by Prenatal Dexamethasone Exposure.

Subchondral Bone Dysplasia Partly Participates in Prenatal Dexamethasone Induced-Osteoarthritis Susceptibility in Female Offspring Rats.

Low miR-92a-3p in oocytes mediates the multigenerational and transgenerational inheritance of poor cartilage quality in rat induced by prenatal dexamethasone exposure

Mirna320a-3P/runx2 Signal Programming Mediates the Transgenerational Inheritance of Inhibited Ovarian Estrogen Synthesis in Female Offspring Rats Induced by Prenatal Dexamethasone Exposure.

The Role of Chondrocyte-to-osteoblast Trans-Differentiation in Fetal Bone Dysplasia of Mice Caused by Prenatal Exposure to Dexamethasone

Prenatal dexamethasone exposure programs the decreased testosterone synthesis in offspring rats by low level of endogenous glucocorticoids

Prenatal Dexamethasone Exposure Induced Ovarian Developmental Toxicity and Transgenerational Effect in Rat Offspring.

Programming of a Developmental Imbalance in Hypothalamic Glutamatergic/gabaergic Afferents Mediates Low Basal Activity of the Hypothalamic-Pituitary-adrenal Axis Induced by Prenatal Dexamethasone Exposure in Male Offspring Rats.

Mitogen‐inducible Gene‐6 Partly Mediates the Inhibitory Effects of Prenatal Dexamethasone Exposure on Endochondral Ossification in Long Bones of Fetal Rats

MiR-133a-3p/Sirt1 epigenetic programming mediates hypercholesterolemia susceptibility in female offspring induced by prenatal dexamethasone exposure

Maternal prednisone exposure during pregnancy elevates susceptibility to osteoporosis in female offspring: The role of mitophagy/FNDC5 alteration in skeletal muscle

Course-, Dose-, and Stage-Dependent Toxic Effects of Prenatal Dexamethasone Exposure on Long Bone Development in Fetal Mice.

Cellular senescence mediates the detrimental effect of prenatal dexamethasone exposure on postnatal long bone growth in mice offspring